Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Solaredge Technologies Inc (SEDG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Solaredge Technologies Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Solaredge Technologies Inc trades at $29.8 (market cap $1.88B). The key difference: Kymera Therapeutics Inc. Common Stock is far larger — about 4.7× Solaredge Technologies Inc's market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, Solaredge Technologies Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Solaredge Technologies Inc for 34 Days on average.
| KYMR | SEDG | |
|---|---|---|
Market Cap | $8.88B | $1.88B |
Volume | 1,028,790 | 4,127,186 |
Sector | Health | Energy |
52-Week High | $127.31 | $78.51 |
52-Week Low | $55.80 | $28.47 |
Typical Hold Time | 0 Days | 34 Days |
Enterprise Value | $8.27B | $1.74B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SolarEdge Technologies (SEDG) trades at $32.53, up 3.34% today, amid a bearish technical outlook and mixed earnings history. The company reported a net loss of $405.45 million in 2025, with negative profit margins and ROE, though revenue grew to $1.18 billion. Recent news highlights legal investigations and volatility driven by solar sector pressures and new AI data center initiatives.
The stock faces significant fundamental challenges with persistent losses and high debt, but analyst consensus suggests a $37 price target with 22.9% buy ratings. Risks include ongoing legal probes, competitive pressures, and reliance on project financing. Upside depends on execution of growth targets, including AI expansion aiming for $2.4 billion revenue by 2029.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Solaredge Technologies Inc
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers. Additionally, the company has nonsolar products targeting energy storage and e-mobility.
Read more on SEDG →
